Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A notice about NIH website terminology changes appears above the ClinicalTrials.gov page. The underlying study record still displays a 403 error.
    Difference
    1%
    Check dated 2026-10-24T19:11:54.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-17T20:16:32.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T20:39:03.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, with the header and footer present but the study content not shown. This indicates an access/server issue rather than a substantive update to the page content.
    Difference
    18%
    Check dated 2026-09-19T20:31:04.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6 instead of v3.6.5, representing a new site build. This appears to be a maintenance or UI deployment rather than a change to study data or content.
    Difference
    0.1%
    Check dated 2026-08-29T20:08:27.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The study record page now shows a server error page, replacing the detailed trial information with a generic error message; the page no longer displays the study's metadata and locations.
    Difference
    17%
    Check dated 2026-08-08T17:46:43.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.